Loading company details...
Beta
Latest Form 4 (Sep 9, 2026): Nur Nicholson (Chief Technology Officer): Grant/Award of 220,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Nur Nicholson, Chief Technology Officer | Grant/Award | 220,000 | n/a |
| Jul 8, 2026 | Kathleen Tregoning, Chief Corporate Affairs Officer | Grant/Award | 175,000 | n/a |
| Jun 11, 2026 | Ronald C. Renaud Jr., CEO & President | Exercise/Conversion | 38,094 | $200.0K |
| Apr 22, 2026 | RTW INVESTMENTS, LP | Conversion | 10,276,820 | n/a |
| Apr 22, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Conversion | 9,477,719 | n/a |
| Apr 20, 2026 | BAIN CAPITAL INVESTORS LLC | Conversion | 17,857,143 | n/a |
| Apr 20, 2026 | Adam Koppel | Conversion | 16,875,000 | n/a |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | Conversion | 16,875,000 | n/a |
| Apr 20, 2026 | Andrew T. Kaplan | Conversion | 17,857,143 | n/a |
| Apr 20, 2026 | Paula Cloghessy, Chief People Officer | Grant/Award | 60,000 | n/a |